Candriam SCA’s Select Medical SEM Stock Holding History

Candriam SCA’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-33,774	Closed	-$433K	–	848
2023 Q1	$433K	Sell	33,774 -36,628	-52%	-$539K	﹤0.01%	799
2022 Q4	$942K	Sell	70,402 -759	-1%	-$9.81K	0.01%	705
2022 Q3	$847K	Buy	+71,161	New	+$1.01M	0.01%	746
2021 Q4	–	Sell	-167,081	Closed	-$4.04M	–	856
2021 Q3	$4.04M	Buy	167,081 +46,059	+38%	+$914K	0.03%	438
2021 Q2	$2.76M	Buy	+121,022	New	+$2.51M	0.02%	527

Other funds holding SEM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Candriam SCA's SEM Position: Q2 2023 in Review

Candriam SCA sold out of Select Medical (SEM) in Q2 2023, closing a stake of 33,774 shares — an estimated $433K sold.

Candriam SCA first reported a position in SEM in Q2 2021 and held it in 5 quarters. The position peaked at $4.04M in Q3 2021. 226 funds tracked by Wall St. Rank hold SEM as of Q2 2023.

Candriam SCA reported no remaining Select Medical position as of Q2 2023 after selling out during the quarter.
Candriam SCA sold 33,774 Select Medical shares in Q2 2023, an estimated $433K.
Candriam SCA first reported a position in Select Medical in Q2 2021 and held it in 5 quarters.
Candriam SCA's Select Medical position peaked at $4.04M in Q3 2021.
226 funds tracked by Wall St. Rank held Select Medical as of Q2 2023.

Based on Candriam SCA's 13F filing for Q2 2023, filed 8 Aug 2023.